Michael Yaron
Concepts (658)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sjogren's Syndrome | 17 | 2001 | 41 | 2.220 |
Why?
| Arthritis, Rheumatoid | 49 | 2006 | 903 | 2.150 |
Why?
| Altitude Sickness | 10 | 2015 | 187 | 1.490 |
Why?
| Synovial Membrane | 13 | 2003 | 65 | 1.220 |
Why?
| Methotrexate | 15 | 1997 | 241 | 1.100 |
Why?
| Osteoarthritis | 13 | 2003 | 170 | 1.080 |
Why?
| Hyaluronic Acid | 19 | 2001 | 181 | 1.080 |
Why?
| Saliva | 7 | 2001 | 222 | 1.030 |
Why?
| Interleukin-1 | 13 | 2004 | 1049 | 0.980 |
Why?
| Balneology | 4 | 2000 | 4 | 0.630 |
Why?
| Antibodies, Antinuclear | 7 | 2001 | 70 | 0.600 |
Why?
| Interleukin-6 | 7 | 2006 | 716 | 0.590 |
Why?
| Arthritis, Psoriatic | 6 | 2000 | 15 | 0.550 |
Why?
| Surveys and Questionnaires | 7 | 2010 | 4625 | 0.550 |
Why?
| Middle Aged | 89 | 2015 | 28753 | 0.550 |
Why?
| Calcium, Dietary | 1 | 2014 | 51 | 0.540 |
Why?
| Communication Barriers | 2 | 2007 | 78 | 0.530 |
Why?
| Female | 118 | 2015 | 63035 | 0.510 |
Why?
| Endothelium | 1 | 2014 | 134 | 0.510 |
Why?
| Antirheumatic Agents | 8 | 2006 | 249 | 0.510 |
Why?
| Prostaglandins E | 9 | 1993 | 56 | 0.500 |
Why?
| Fibromyalgia | 4 | 2009 | 47 | 0.500 |
Why?
| Humans | 170 | 2015 | 113846 | 0.490 |
Why?
| Rheumatic Diseases | 4 | 2010 | 45 | 0.480 |
Why?
| Arteries | 1 | 2014 | 238 | 0.480 |
Why?
| Nitric Oxide | 4 | 2003 | 883 | 0.470 |
Why?
| Altitude | 5 | 2004 | 467 | 0.470 |
Why?
| Low Back Pain | 3 | 1998 | 92 | 0.450 |
Why?
| Adult | 77 | 2015 | 31979 | 0.450 |
Why?
| Travel | 3 | 2008 | 106 | 0.440 |
Why?
| Male | 95 | 2015 | 60993 | 0.440 |
Why?
| Aged | 57 | 2015 | 20109 | 0.440 |
Why?
| Dietary Supplements | 1 | 2014 | 436 | 0.410 |
Why?
| Medical Order Entry Systems | 1 | 2010 | 38 | 0.400 |
Why?
| Gold | 6 | 1997 | 105 | 0.380 |
Why?
| Israel | 11 | 2010 | 39 | 0.380 |
Why?
| Aurothioglucose | 3 | 1997 | 6 | 0.370 |
Why?
| Fibroblasts | 15 | 1993 | 906 | 0.360 |
Why?
| Physical Examination | 3 | 2015 | 245 | 0.360 |
Why?
| Drug Eruptions | 3 | 1997 | 26 | 0.360 |
Why?
| Lupus Erythematosus, Systemic | 10 | 2003 | 255 | 0.350 |
Why?
| Knee Joint | 5 | 2003 | 296 | 0.350 |
Why?
| Spondylitis, Ankylosing | 4 | 2007 | 37 | 0.350 |
Why?
| Child Welfare | 2 | 2008 | 219 | 0.340 |
Why?
| Matrix Metalloproteinase 3 | 2 | 2006 | 24 | 0.340 |
Why?
| Synovial Fluid | 6 | 1989 | 56 | 0.340 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2003 | 326 | 0.330 |
Why?
| Sleep Wake Disorders | 2 | 2004 | 295 | 0.320 |
Why?
| Severity of Illness Index | 4 | 2007 | 2828 | 0.320 |
Why?
| Professional-Family Relations | 1 | 2008 | 136 | 0.320 |
Why?
| Penicillamine | 5 | 1991 | 26 | 0.320 |
Why?
| Child Behavior | 2 | 2007 | 259 | 0.310 |
Why?
| Wilderness | 2 | 2015 | 17 | 0.310 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2004 | 1251 | 0.310 |
Why?
| Receptors, Interleukin-2 | 3 | 2000 | 66 | 0.290 |
Why?
| Length of Stay | 1 | 2010 | 1062 | 0.290 |
Why?
| Health Education | 1 | 2008 | 321 | 0.280 |
Why?
| Heat Stroke | 1 | 2004 | 3 | 0.280 |
Why?
| Sensitivity and Specificity | 7 | 2010 | 1930 | 0.270 |
Why?
| Ginger | 1 | 2003 | 1 | 0.270 |
Why?
| Osteoarthritis, Knee | 2 | 2003 | 181 | 0.270 |
Why?
| Tomography, X-Ray Computed | 8 | 1998 | 2380 | 0.270 |
Why?
| Hydroxybutyrates | 1 | 2003 | 13 | 0.260 |
Why?
| Emergency Service, Hospital | 3 | 2010 | 1755 | 0.260 |
Why?
| Phytotherapy | 1 | 2003 | 69 | 0.260 |
Why?
| Anthraquinones | 2 | 2000 | 9 | 0.250 |
Why?
| Aniline Compounds | 1 | 2003 | 65 | 0.250 |
Why?
| Population Surveillance | 1 | 2007 | 439 | 0.250 |
Why?
| Cervical Vertebrae | 2 | 1995 | 111 | 0.250 |
Why?
| Osteonecrosis | 2 | 1996 | 18 | 0.250 |
Why?
| Glycosaminoglycans | 4 | 1999 | 94 | 0.250 |
Why?
| Prednisone | 8 | 2003 | 246 | 0.250 |
Why?
| Mud Therapy | 3 | 2000 | 3 | 0.240 |
Why?
| Dinoprostone | 3 | 1999 | 191 | 0.240 |
Why?
| Respiration | 1 | 2003 | 194 | 0.240 |
Why?
| Plant Extracts | 1 | 2003 | 179 | 0.230 |
Why?
| Receptors, Interleukin-1 | 2 | 2001 | 250 | 0.230 |
Why?
| Hydroxychloroquine | 2 | 1999 | 58 | 0.230 |
Why?
| Prospective Studies | 15 | 2004 | 6250 | 0.230 |
Why?
| Minocycline | 5 | 1999 | 36 | 0.230 |
Why?
| Guanidines | 1 | 2001 | 42 | 0.230 |
Why?
| Retinal Hemorrhage | 1 | 2001 | 22 | 0.220 |
Why?
| Pulmonary Edema | 2 | 2001 | 162 | 0.220 |
Why?
| Wounds and Injuries | 5 | 2015 | 911 | 0.220 |
Why?
| Back Pain | 3 | 2000 | 43 | 0.220 |
Why?
| Dose-Response Relationship, Drug | 7 | 2014 | 2229 | 0.220 |
Why?
| Arthritis, Juvenile | 2 | 1992 | 37 | 0.210 |
Why?
| Hand | 5 | 2001 | 137 | 0.210 |
Why?
| Nitric Oxide Synthase | 1 | 2001 | 250 | 0.210 |
Why?
| Amitriptyline | 1 | 1999 | 22 | 0.210 |
Why?
| Fluoxetine | 1 | 1999 | 45 | 0.200 |
Why?
| Emergency Treatment | 2 | 2004 | 129 | 0.200 |
Why?
| Adrenal Cortex Hormones | 3 | 1999 | 492 | 0.200 |
Why?
| Immunosuppressive Agents | 2 | 2003 | 676 | 0.200 |
Why?
| Amyloidosis | 4 | 2002 | 41 | 0.200 |
Why?
| Tears | 1 | 1998 | 10 | 0.190 |
Why?
| Calcinosis | 3 | 1998 | 297 | 0.190 |
Why?
| Antiphospholipid Syndrome | 2 | 1998 | 26 | 0.190 |
Why?
| Aged, 80 and over | 13 | 2010 | 6796 | 0.190 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 1227 | 0.190 |
Why?
| Resuscitation | 2 | 1994 | 293 | 0.190 |
Why?
| Eye Proteins | 1 | 1998 | 79 | 0.190 |
Why?
| Analgesia, Epidural | 1 | 1998 | 25 | 0.190 |
Why?
| Biomarkers | 12 | 2000 | 3501 | 0.180 |
Why?
| Pain Measurement | 6 | 2004 | 525 | 0.180 |
Why?
| Leukocytes | 7 | 2002 | 301 | 0.180 |
Why?
| Down-Regulation | 1 | 2001 | 682 | 0.180 |
Why?
| Cross-Over Studies | 2 | 2014 | 484 | 0.180 |
Why?
| Osteoporosis | 2 | 1999 | 195 | 0.180 |
Why?
| Disasters | 1 | 1999 | 87 | 0.180 |
Why?
| RNA, Small Cytoplasmic | 1 | 1997 | 9 | 0.170 |
Why?
| Acute Disease | 6 | 2007 | 1000 | 0.170 |
Why?
| Bronchial Spasm | 1 | 1996 | 9 | 0.170 |
Why?
| Hypoxia | 1 | 2004 | 940 | 0.170 |
Why?
| Capnography | 1 | 1996 | 10 | 0.170 |
Why?
| Antibodies, Antiphospholipid | 1 | 1996 | 25 | 0.170 |
Why?
| Disabled Persons | 2 | 2015 | 145 | 0.160 |
Why?
| Mortality | 1 | 1999 | 328 | 0.160 |
Why?
| Enzyme Inhibitors | 1 | 2001 | 945 | 0.160 |
Why?
| Sulfasalazine | 2 | 1997 | 21 | 0.160 |
Why?
| Polychondritis, Relapsing | 2 | 1987 | 3 | 0.160 |
Why?
| Anti-Inflammatory Agents | 4 | 2003 | 460 | 0.160 |
Why?
| Ultraviolet Rays | 1 | 2000 | 418 | 0.160 |
Why?
| Rheumatoid Nodule | 3 | 2001 | 6 | 0.160 |
Why?
| Thermometers | 1 | 1995 | 9 | 0.160 |
Why?
| Brown-Sequard Syndrome | 1 | 1995 | 4 | 0.160 |
Why?
| Thermography | 1 | 1995 | 14 | 0.150 |
Why?
| Eicosanoids | 1 | 1996 | 65 | 0.150 |
Why?
| C-Reactive Protein | 5 | 1999 | 363 | 0.150 |
Why?
| Cells, Cultured | 11 | 2003 | 4429 | 0.150 |
Why?
| Tympanic Membrane | 1 | 1995 | 24 | 0.150 |
Why?
| Cyanoacrylates | 1 | 1995 | 6 | 0.150 |
Why?
| Autoimmune Diseases | 4 | 2000 | 434 | 0.150 |
Why?
| Medical History Taking | 1 | 2015 | 127 | 0.150 |
Why?
| Foot Ulcer | 1 | 1995 | 4 | 0.150 |
Why?
| Joint Deformities, Acquired | 2 | 2000 | 12 | 0.150 |
Why?
| Tissue Adhesives | 1 | 1995 | 16 | 0.150 |
Why?
| Jews | 5 | 2009 | 22 | 0.150 |
Why?
| HLA Antigens | 5 | 1991 | 240 | 0.150 |
Why?
| Hand Injuries | 1 | 1995 | 30 | 0.150 |
Why?
| Mountaineering | 3 | 2008 | 61 | 0.150 |
Why?
| Colitis, Ulcerative | 1 | 1996 | 104 | 0.150 |
Why?
| Hospital Design and Construction | 1 | 1994 | 5 | 0.150 |
Why?
| HLA-DR Antigens | 2 | 1994 | 235 | 0.150 |
Why?
| Lacerations | 1 | 1995 | 28 | 0.150 |
Why?
| Cartilage, Articular | 4 | 2001 | 287 | 0.140 |
Why?
| Creatinine | 3 | 2014 | 461 | 0.140 |
Why?
| Wounds, Penetrating | 1 | 1995 | 81 | 0.140 |
Why?
| Joints | 4 | 2004 | 84 | 0.140 |
Why?
| Fever | 2 | 1996 | 316 | 0.140 |
Why?
| Administration, Oral | 3 | 2014 | 798 | 0.140 |
Why?
| Microbial Collagenase | 3 | 1990 | 12 | 0.140 |
Why?
| Recommended Dietary Allowances | 1 | 2014 | 15 | 0.140 |
Why?
| Hypersensitivity | 1 | 1998 | 285 | 0.140 |
Why?
| Metacarpophalangeal Joint | 1 | 1993 | 11 | 0.140 |
Why?
| Androgen-Insensitivity Syndrome | 1 | 2013 | 5 | 0.130 |
Why?
| Phosphorus | 1 | 2014 | 88 | 0.130 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 909 | 0.130 |
Why?
| Calcitriol | 1 | 1993 | 50 | 0.130 |
Why?
| Parathyroid Hormone | 1 | 2014 | 113 | 0.130 |
Why?
| Environment | 1 | 2015 | 400 | 0.130 |
Why?
| Blood Sedimentation | 6 | 2000 | 35 | 0.130 |
Why?
| Healthy Volunteers | 1 | 2014 | 219 | 0.130 |
Why?
| Growth Inhibitors | 1 | 1993 | 54 | 0.130 |
Why?
| Octreotide | 2 | 2004 | 24 | 0.130 |
Why?
| Reference Values | 4 | 2007 | 877 | 0.130 |
Why?
| Random Allocation | 1 | 2014 | 402 | 0.130 |
Why?
| Child, Preschool | 8 | 2007 | 9717 | 0.120 |
Why?
| Synovitis | 4 | 1993 | 21 | 0.120 |
Why?
| Hydrocortisone | 6 | 2001 | 322 | 0.120 |
Why?
| Acute-Phase Reaction | 2 | 1989 | 33 | 0.120 |
Why?
| Leucovorin | 2 | 1990 | 42 | 0.120 |
Why?
| Hyperemia | 1 | 1992 | 38 | 0.120 |
Why?
| Carpal Bones | 1 | 1992 | 12 | 0.120 |
Why?
| Colorado | 4 | 2010 | 4581 | 0.120 |
Why?
| Radiography | 7 | 2001 | 828 | 0.120 |
Why?
| Ulna | 1 | 1992 | 19 | 0.120 |
Why?
| Time Factors | 14 | 2003 | 7060 | 0.120 |
Why?
| Point Mutation | 1 | 2013 | 258 | 0.120 |
Why?
| Prevalence | 3 | 2010 | 2407 | 0.120 |
Why?
| Receptors, Androgen | 1 | 2013 | 124 | 0.120 |
Why?
| Erythema Nodosum | 1 | 1991 | 3 | 0.120 |
Why?
| Eye Diseases | 2 | 1992 | 83 | 0.120 |
Why?
| Wound Healing | 1 | 1995 | 331 | 0.120 |
Why?
| Measles virus | 2 | 1981 | 12 | 0.120 |
Why?
| Rubella virus | 2 | 1981 | 7 | 0.120 |
Why?
| Red-Cell Aplasia, Pure | 1 | 1991 | 1 | 0.110 |
Why?
| Vitamin D | 2 | 2014 | 329 | 0.110 |
Why?
| Airway Obstruction | 2 | 1996 | 161 | 0.110 |
Why?
| Spinal Injuries | 1 | 1992 | 51 | 0.110 |
Why?
| Vasculitis | 3 | 2001 | 87 | 0.110 |
Why?
| Child | 10 | 2015 | 17711 | 0.110 |
Why?
| Treatment Outcome | 12 | 2004 | 9002 | 0.110 |
Why?
| Urinary Tract Infections | 1 | 1992 | 123 | 0.110 |
Why?
| Interleukin-10 | 2 | 2006 | 333 | 0.110 |
Why?
| Myocardial Infarction | 2 | 2014 | 1121 | 0.110 |
Why?
| Reproducibility of Results | 3 | 2007 | 2905 | 0.110 |
Why?
| Digital Rectal Examination | 1 | 2010 | 8 | 0.100 |
Why?
| Arthritis | 4 | 2000 | 108 | 0.100 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 1992 | 139 | 0.100 |
Why?
| Aspirin | 3 | 2003 | 317 | 0.100 |
Why?
| Testosterone | 1 | 2013 | 307 | 0.100 |
Why?
| Occult Blood | 1 | 2010 | 25 | 0.100 |
Why?
| Infant | 7 | 2004 | 8090 | 0.100 |
Why?
| Anti-Bacterial Agents | 5 | 2003 | 1331 | 0.100 |
Why?
| Receptors, Neurokinin-1 | 1 | 2009 | 15 | 0.100 |
Why?
| Sarcoidosis | 2 | 2002 | 126 | 0.100 |
Why?
| Jaundice | 1 | 1989 | 15 | 0.100 |
Why?
| Diclofenac | 1 | 1989 | 12 | 0.100 |
Why?
| Intervertebral Disc Displacement | 1 | 1990 | 32 | 0.100 |
Why?
| Poly I-C | 3 | 1980 | 59 | 0.100 |
Why?
| Ligaments, Articular | 1 | 1990 | 48 | 0.100 |
Why?
| Heart Rate | 1 | 2014 | 844 | 0.100 |
Why?
| Spinal Diseases | 1 | 1990 | 45 | 0.100 |
Why?
| Temporomandibular Joint Disorders | 1 | 1989 | 8 | 0.100 |
Why?
| Temporomandibular Joint | 1 | 1989 | 11 | 0.100 |
Why?
| Interferon-gamma | 2 | 1990 | 804 | 0.100 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 65 | 0.100 |
Why?
| Anemia, Aplastic | 1 | 1989 | 34 | 0.100 |
Why?
| Cryoglobulinemia | 1 | 1988 | 5 | 0.100 |
Why?
| Keratosis | 1 | 1988 | 17 | 0.100 |
Why?
| Familial Mediterranean Fever | 1 | 1988 | 7 | 0.100 |
Why?
| Ichthyosis | 1 | 1988 | 12 | 0.100 |
Why?
| Biological Factors | 1 | 1989 | 37 | 0.100 |
Why?
| Scleroderma, Systemic | 2 | 2000 | 89 | 0.090 |
Why?
| Recombinant Proteins | 5 | 1997 | 1458 | 0.090 |
Why?
| Auranofin | 1 | 1988 | 9 | 0.090 |
Why?
| Interferons | 3 | 1980 | 135 | 0.090 |
Why?
| Stomatitis, Aphthous | 1 | 1988 | 11 | 0.090 |
Why?
| Chyle | 1 | 1988 | 3 | 0.090 |
Why?
| Age Factors | 6 | 2015 | 3330 | 0.090 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 1988 | 81 | 0.090 |
Why?
| alpha 1-Antitrypsin | 1 | 2009 | 120 | 0.090 |
Why?
| Language | 1 | 2010 | 236 | 0.090 |
Why?
| Immunoglobulins | 1 | 1988 | 152 | 0.090 |
Why?
| Lipopolysaccharides | 2 | 2003 | 960 | 0.090 |
Why?
| Ligaments | 1 | 1988 | 38 | 0.090 |
Why?
| Seasons | 1 | 2010 | 439 | 0.090 |
Why?
| Culture Techniques | 4 | 1999 | 94 | 0.090 |
Why?
| Interviews as Topic | 1 | 2010 | 629 | 0.090 |
Why?
| Adolescent | 13 | 2015 | 18736 | 0.090 |
Why?
| Diagnosis, Differential | 5 | 2003 | 1432 | 0.090 |
Why?
| HLA-B27 Antigen | 1 | 2007 | 12 | 0.090 |
Why?
| Peripheral Nervous System Diseases | 1 | 1988 | 142 | 0.090 |
Why?
| Cysts | 1 | 1988 | 88 | 0.080 |
Why?
| Double-Blind Method | 3 | 2003 | 1673 | 0.080 |
Why?
| Edema | 1 | 1988 | 116 | 0.080 |
Why?
| Remission Induction | 3 | 1993 | 265 | 0.080 |
Why?
| Joint Diseases | 1 | 1988 | 63 | 0.080 |
Why?
| Academic Medical Centers | 1 | 2010 | 442 | 0.080 |
Why?
| Kidney | 4 | 2003 | 1211 | 0.080 |
Why?
| Skin | 5 | 2003 | 702 | 0.080 |
Why?
| Demography | 2 | 1999 | 294 | 0.080 |
Why?
| Indomethacin | 4 | 1989 | 86 | 0.080 |
Why?
| Evaluation Studies as Topic | 3 | 1999 | 226 | 0.080 |
Why?
| Antibodies, Monoclonal | 2 | 2004 | 1302 | 0.080 |
Why?
| Spine | 1 | 1988 | 126 | 0.080 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2006 | 20 | 0.080 |
Why?
| Chronic Disease | 4 | 2015 | 1681 | 0.080 |
Why?
| Blood Proteins | 1 | 1988 | 265 | 0.080 |
Why?
| Syndrome | 4 | 1993 | 347 | 0.080 |
Why?
| Shoulder Joint | 1 | 1988 | 147 | 0.080 |
Why?
| Isoxazoles | 1 | 2006 | 57 | 0.080 |
Why?
| Monitoring, Physiologic | 2 | 2004 | 277 | 0.080 |
Why?
| Proteinuria | 2 | 2002 | 103 | 0.080 |
Why?
| Sports | 2 | 2015 | 153 | 0.080 |
Why?
| Sialoglycoproteins | 2 | 2000 | 185 | 0.080 |
Why?
| Liver | 2 | 1992 | 1867 | 0.070 |
Why?
| Primary Prevention | 1 | 2008 | 214 | 0.070 |
Why?
| Retrospective Studies | 9 | 2010 | 11340 | 0.070 |
Why?
| Pedigree | 4 | 2000 | 518 | 0.070 |
Why?
| Incidence | 3 | 2002 | 2470 | 0.070 |
Why?
| Oxygen | 3 | 2003 | 892 | 0.070 |
Why?
| Rheumatoid Factor | 2 | 2001 | 138 | 0.070 |
Why?
| Stimulation, Chemical | 4 | 1989 | 71 | 0.070 |
Why?
| Crohn Disease | 2 | 2004 | 168 | 0.070 |
Why?
| Oximetry | 2 | 2003 | 81 | 0.070 |
Why?
| Biopsy, Needle | 2 | 1999 | 196 | 0.070 |
Why?
| Combined Modality Therapy | 2 | 2000 | 1243 | 0.070 |
Why?
| Patient Discharge | 1 | 2010 | 743 | 0.070 |
Why?
| Crotonates | 1 | 2003 | 2 | 0.070 |
Why?
| Toluidines | 1 | 2003 | 3 | 0.070 |
Why?
| Tenosynovitis | 1 | 2003 | 11 | 0.070 |
Why?
| Autoantibodies | 4 | 1999 | 1222 | 0.070 |
Why?
| Ankle Joint | 2 | 2002 | 148 | 0.070 |
Why?
| Cell Division | 4 | 1993 | 880 | 0.070 |
Why?
| Hypnosis | 1 | 1983 | 8 | 0.070 |
Why?
| Mycobacterium kansasii | 1 | 2003 | 15 | 0.070 |
Why?
| Carpal Tunnel Syndrome | 1 | 2003 | 18 | 0.070 |
Why?
| Pemphigus | 1 | 1983 | 7 | 0.060 |
Why?
| Tuberculosis, Miliary | 1 | 2003 | 5 | 0.060 |
Why?
| Tuberculosis, Cutaneous | 1 | 2003 | 4 | 0.060 |
Why?
| Acne Vulgaris | 3 | 1998 | 28 | 0.060 |
Why?
| Inflammation | 3 | 1989 | 2451 | 0.060 |
Why?
| Fasciitis | 1 | 1982 | 7 | 0.060 |
Why?
| Lip | 2 | 2001 | 22 | 0.060 |
Why?
| Technetium Tc 99m Exametazime | 1 | 2002 | 2 | 0.060 |
Why?
| Lipoproteins | 1 | 1983 | 182 | 0.060 |
Why?
| Spondylarthropathies | 1 | 2002 | 5 | 0.060 |
Why?
| Tidal Volume | 1 | 2003 | 82 | 0.060 |
Why?
| Tuberculosis, Osteoarticular | 1 | 2002 | 2 | 0.060 |
Why?
| Wakefulness | 1 | 2004 | 167 | 0.060 |
Why?
| Athletes | 2 | 2015 | 271 | 0.060 |
Why?
| Drug Evaluation, Preclinical | 1 | 2003 | 192 | 0.060 |
Why?
| Immunoglobulin G | 3 | 2001 | 798 | 0.060 |
Why?
| Nitriles | 1 | 2003 | 163 | 0.060 |
Why?
| History, 20th Century | 1 | 2004 | 310 | 0.060 |
Why?
| Respiratory Function Tests | 2 | 2003 | 595 | 0.060 |
Why?
| Hepatitis B | 1 | 2002 | 42 | 0.060 |
Why?
| Arthritis, Experimental | 1 | 2004 | 129 | 0.060 |
Why?
| Osteoporosis, Postmenopausal | 2 | 2000 | 42 | 0.060 |
Why?
| Radionuclide Imaging | 3 | 2002 | 159 | 0.060 |
Why?
| Hepatitis B Vaccines | 1 | 2002 | 43 | 0.060 |
Why?
| Follow-Up Studies | 3 | 1999 | 4906 | 0.060 |
Why?
| Glucocorticoids | 3 | 2002 | 539 | 0.060 |
Why?
| Newcastle disease virus | 1 | 1981 | 19 | 0.060 |
Why?
| Cell Survival | 2 | 2003 | 1188 | 0.060 |
Why?
| Adenoviruses, Human | 1 | 1981 | 28 | 0.060 |
Why?
| Biopsy | 2 | 1999 | 1065 | 0.060 |
Why?
| Family Health | 2 | 1994 | 209 | 0.060 |
Why?
| Complement C3b | 1 | 2001 | 33 | 0.060 |
Why?
| Uric Acid | 3 | 2003 | 353 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2009 | 572 | 0.060 |
Why?
| Prednisolone | 2 | 1992 | 73 | 0.060 |
Why?
| fas Receptor | 1 | 2001 | 107 | 0.060 |
Why?
| Environmental Medicine | 1 | 2001 | 4 | 0.060 |
Why?
| Immunocompromised Host | 1 | 2003 | 218 | 0.060 |
Why?
| Young Adult | 2 | 2015 | 10971 | 0.060 |
Why?
| Nitroprusside | 1 | 2001 | 97 | 0.060 |
Why?
| Movement | 1 | 2004 | 274 | 0.060 |
Why?
| Emergencies | 2 | 1996 | 166 | 0.060 |
Why?
| Genetic Predisposition to Disease | 2 | 2009 | 2424 | 0.060 |
Why?
| Gastric Antral Vascular Ectasia | 1 | 2000 | 1 | 0.060 |
Why?
| Cerebrovascular Circulation | 1 | 2003 | 186 | 0.050 |
Why?
| Carbon Dioxide | 1 | 2003 | 249 | 0.050 |
Why?
| Hemoglobins | 1 | 2003 | 298 | 0.050 |
Why?
| Xanthine | 1 | 2000 | 10 | 0.050 |
Why?
| United States | 3 | 2008 | 12329 | 0.050 |
Why?
| Eosinophilia | 1 | 1982 | 167 | 0.050 |
Why?
| Radiopharmaceuticals | 1 | 2002 | 207 | 0.050 |
Why?
| Skiing | 1 | 2001 | 45 | 0.050 |
Why?
| Xanthine Dehydrogenase | 1 | 2000 | 43 | 0.050 |
Why?
| Salivary Glands | 2 | 1997 | 41 | 0.050 |
Why?
| Leg | 2 | 1996 | 240 | 0.050 |
Why?
| Sulfur Radioisotopes | 1 | 1999 | 20 | 0.050 |
Why?
| Pneumococcal Vaccines | 1 | 2001 | 134 | 0.050 |
Why?
| Fractures, Stress | 1 | 2000 | 28 | 0.050 |
Why?
| Monocytes | 2 | 2001 | 517 | 0.050 |
Why?
| Anxiety Disorders | 1 | 1983 | 290 | 0.050 |
Why?
| Neck Pain | 1 | 2000 | 31 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 173 | 0.050 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 1999 | 33 | 0.050 |
Why?
| HLA-DR4 Antigen | 2 | 1992 | 72 | 0.050 |
Why?
| Drug Therapy, Combination | 4 | 2003 | 1004 | 0.050 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 1999 | 40 | 0.050 |
Why?
| Haplotypes | 2 | 1992 | 547 | 0.050 |
Why?
| Lipids | 1 | 1983 | 629 | 0.050 |
Why?
| Xerostomia | 1 | 1999 | 16 | 0.050 |
Why?
| Alkaline Phosphatase | 2 | 1992 | 159 | 0.050 |
Why?
| Age of Onset | 1 | 2001 | 494 | 0.050 |
Why?
| Mycobacterium tuberculosis | 1 | 2002 | 251 | 0.050 |
Why?
| Translations | 1 | 1999 | 15 | 0.050 |
Why?
| Hemiplegia | 1 | 1998 | 15 | 0.050 |
Why?
| Hand Strength | 1 | 2000 | 94 | 0.050 |
Why?
| Endotoxins | 1 | 1980 | 265 | 0.050 |
Why?
| Pilot Projects | 3 | 2004 | 1421 | 0.050 |
Why?
| DNA, Viral | 1 | 1981 | 442 | 0.050 |
Why?
| Diagnostic Errors | 1 | 2000 | 158 | 0.050 |
Why?
| Analysis of Variance | 1 | 2003 | 1517 | 0.050 |
Why?
| Lumbosacral Region | 2 | 1990 | 51 | 0.050 |
Why?
| Recurrence | 2 | 1992 | 967 | 0.050 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2003 | 286 | 0.050 |
Why?
| Paresis | 1 | 1998 | 20 | 0.050 |
Why?
| Magnetic Resonance Imaging | 4 | 2002 | 3049 | 0.050 |
Why?
| Drug Administration Schedule | 2 | 1992 | 825 | 0.050 |
Why?
| Drug Synergism | 2 | 1990 | 360 | 0.050 |
Why?
| Immunoglobulins, Intravenous | 1 | 2000 | 150 | 0.050 |
Why?
| Infant Behavior | 1 | 1998 | 38 | 0.050 |
Why?
| Immunoglobulin A, Secretory | 1 | 1997 | 10 | 0.050 |
Why?
| Immunologic Factors | 1 | 2000 | 228 | 0.040 |
Why?
| beta 2-Microglobulin | 1 | 1997 | 45 | 0.040 |
Why?
| Lactoferrin | 1 | 1997 | 30 | 0.040 |
Why?
| Inflammatory Bowel Diseases | 2 | 2002 | 248 | 0.040 |
Why?
| Appetite | 1 | 1998 | 70 | 0.040 |
Why?
| Polymyalgia Rheumatica | 1 | 1997 | 2 | 0.040 |
Why?
| Electrolytes | 1 | 1997 | 69 | 0.040 |
Why?
| RNA, Viral | 1 | 1981 | 598 | 0.040 |
Why?
| Folic Acid Antagonists | 1 | 1997 | 9 | 0.040 |
Why?
| Health Status | 2 | 2004 | 773 | 0.040 |
Why?
| Cartilage | 1 | 1999 | 183 | 0.040 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 83 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 1998 | 82 | 0.040 |
Why?
| Prognosis | 2 | 1996 | 3544 | 0.040 |
Why?
| Recombinant Fusion Proteins | 1 | 2000 | 694 | 0.040 |
Why?
| Appendicitis | 1 | 1998 | 109 | 0.040 |
Why?
| Psoriasis | 2 | 2000 | 78 | 0.040 |
Why?
| Dermatitis, Allergic Contact | 1 | 1998 | 62 | 0.040 |
Why?
| Forced Expiratory Flow Rates | 1 | 1996 | 17 | 0.040 |
Why?
| Histocompatibility Testing | 1 | 1997 | 134 | 0.040 |
Why?
| Drug Hypersensitivity | 1 | 1998 | 83 | 0.040 |
Why?
| Pain Clinics | 1 | 1996 | 3 | 0.040 |
Why?
| Gene Frequency | 2 | 2009 | 572 | 0.040 |
Why?
| Blood Platelets | 2 | 1978 | 388 | 0.040 |
Why?
| Chiropractic | 1 | 1996 | 6 | 0.040 |
Why?
| Thromboxane B2 | 1 | 1996 | 28 | 0.040 |
Why?
| Patella | 1 | 1996 | 26 | 0.040 |
Why?
| Acupuncture Therapy | 1 | 1996 | 15 | 0.040 |
Why?
| Cohort Studies | 3 | 1998 | 5011 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2002 | 2025 | 0.040 |
Why?
| Radioimmunoassay | 1 | 1996 | 180 | 0.040 |
Why?
| Menopause | 1 | 1999 | 251 | 0.040 |
Why?
| Mouth Diseases | 1 | 1996 | 50 | 0.040 |
Why?
| Ribonucleoproteins | 1 | 1997 | 109 | 0.040 |
Why?
| Adrenergic beta-Agonists | 1 | 1996 | 143 | 0.040 |
Why?
| Risk Assessment | 2 | 2015 | 3147 | 0.040 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1995 | 20 | 0.040 |
Why?
| Poliomyelitis | 1 | 1995 | 27 | 0.040 |
Why?
| Risk Factors | 4 | 2015 | 9050 | 0.040 |
Why?
| Wilderness Medicine | 1 | 2015 | 41 | 0.040 |
Why?
| Thrombophlebitis | 1 | 1995 | 8 | 0.040 |
Why?
| Maintenance and Engineering, Hospital | 1 | 1994 | 1 | 0.040 |
Why?
| Pregnancy | 4 | 2015 | 5290 | 0.040 |
Why?
| Abdomen | 2 | 2002 | 127 | 0.040 |
Why?
| Reference Standards | 1 | 1995 | 194 | 0.040 |
Why?
| Mutation | 2 | 2009 | 3447 | 0.040 |
Why?
| Rectum | 1 | 1995 | 151 | 0.030 |
Why?
| Angiography | 1 | 1995 | 158 | 0.030 |
Why?
| Antibodies, Antineutrophil Cytoplasmic | 3 | 1999 | 30 | 0.030 |
Why?
| Macrophages | 1 | 2001 | 1343 | 0.030 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1993 | 2 | 0.030 |
Why?
| Cholesterol | 2 | 1988 | 386 | 0.030 |
Why?
| Food Hypersensitivity | 1 | 1998 | 223 | 0.030 |
Why?
| Sperm Injections, Intracytoplasmic | 1 | 2013 | 5 | 0.030 |
Why?
| Semen Analysis | 1 | 2013 | 13 | 0.030 |
Why?
| Sperm Count | 1 | 2013 | 19 | 0.030 |
Why?
| Parents | 1 | 2002 | 1122 | 0.030 |
Why?
| Ischemia | 1 | 1996 | 314 | 0.030 |
Why?
| Autoantigens | 1 | 1997 | 411 | 0.030 |
Why?
| Analgesics | 1 | 1995 | 157 | 0.030 |
Why?
| Hyperostosis, Sternocostoclavicular | 1 | 1993 | 1 | 0.030 |
Why?
| Blotting, Western | 1 | 1997 | 1316 | 0.030 |
Why?
| Infertility, Male | 1 | 2013 | 58 | 0.030 |
Why?
| Infliximab | 2 | 2004 | 92 | 0.030 |
Why?
| Collagenases | 1 | 1993 | 23 | 0.030 |
Why?
| Axis, Cervical Vertebra | 1 | 1992 | 6 | 0.030 |
Why?
| Cervical Atlas | 1 | 1992 | 5 | 0.030 |
Why?
| Linear Models | 1 | 1995 | 909 | 0.030 |
Why?
| Transaminases | 1 | 1992 | 23 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2013 | 309 | 0.030 |
Why?
| Radius | 1 | 1992 | 31 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 1995 | 669 | 0.030 |
Why?
| Blood Urea Nitrogen | 2 | 2003 | 63 | 0.030 |
Why?
| Atmosphere Exposure Chambers | 1 | 1991 | 10 | 0.030 |
Why?
| Infant, Newborn | 4 | 2013 | 5080 | 0.030 |
Why?
| Serotyping | 1 | 1991 | 32 | 0.030 |
Why?
| Respiratory Tract Diseases | 1 | 1993 | 158 | 0.030 |
Why?
| Infant, Premature | 1 | 1995 | 449 | 0.030 |
Why?
| Rats | 3 | 2004 | 6387 | 0.030 |
Why?
| Sleep | 1 | 1998 | 710 | 0.030 |
Why?
| Hyperbaric Oxygenation | 1 | 1991 | 45 | 0.030 |
Why?
| Collagen | 2 | 1991 | 449 | 0.030 |
Why?
| Kidney Function Tests | 2 | 2003 | 159 | 0.030 |
Why?
| Dactinomycin | 2 | 1987 | 31 | 0.030 |
Why?
| Pain | 2 | 2001 | 745 | 0.030 |
Why?
| Apoptosis | 1 | 2001 | 2675 | 0.030 |
Why?
| Drug Antagonism | 1 | 1990 | 9 | 0.030 |
Why?
| Dyspnea | 1 | 1992 | 186 | 0.030 |
Why?
| Crystallization | 2 | 1988 | 165 | 0.030 |
Why?
| Logistic Models | 1 | 1996 | 2053 | 0.030 |
Why?
| Adaptation, Physiological | 1 | 1995 | 537 | 0.030 |
Why?
| Anticoagulants | 1 | 1995 | 534 | 0.030 |
Why?
| Spinal Stenosis | 1 | 1990 | 25 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2004 | 3910 | 0.030 |
Why?
| Antibody Formation | 3 | 2002 | 306 | 0.030 |
Why?
| Asthma | 3 | 2003 | 1933 | 0.030 |
Why?
| Self Concept | 1 | 1991 | 227 | 0.030 |
Why?
| Drug Combinations | 1 | 1990 | 300 | 0.020 |
Why?
| Etidronic Acid | 2 | 1999 | 3 | 0.020 |
Why?
| Mandibular Condyle | 1 | 1989 | 7 | 0.020 |
Why?
| Injections, Intravenous | 1 | 1989 | 255 | 0.020 |
Why?
| Congo Red | 1 | 1988 | 11 | 0.020 |
Why?
| Raynaud Disease | 1 | 1988 | 6 | 0.020 |
Why?
| Accidents | 1 | 1989 | 42 | 0.020 |
Why?
| HLA-A Antigens | 2 | 1993 | 46 | 0.020 |
Why?
| HLA-B35 Antigen | 1 | 1988 | 3 | 0.020 |
Why?
| Azathioprine | 2 | 1992 | 50 | 0.020 |
Why?
| Periarthritis | 1 | 1988 | 1 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 1995 | 3027 | 0.020 |
Why?
| Serum Amyloid P-Component | 1 | 1987 | 4 | 0.020 |
Why?
| Calcium Phosphates | 1 | 1988 | 27 | 0.020 |
Why?
| Staining and Labeling | 1 | 1988 | 171 | 0.020 |
Why?
| Point-of-Care Systems | 1 | 2010 | 158 | 0.020 |
Why?
| Smoking | 1 | 1996 | 1632 | 0.020 |
Why?
| Cycloheximide | 1 | 1987 | 72 | 0.020 |
Why?
| Complement C4 | 1 | 1987 | 24 | 0.020 |
Why?
| Vaccination | 1 | 1995 | 962 | 0.020 |
Why?
| Pregnancy Complications | 1 | 1993 | 483 | 0.020 |
Why?
| Population | 1 | 2007 | 37 | 0.020 |
Why?
| Accidental Falls | 1 | 1989 | 153 | 0.020 |
Why?
| Coronary Disease | 2 | 1995 | 469 | 0.020 |
Why?
| Alleles | 1 | 2009 | 905 | 0.020 |
Why?
| Odds Ratio | 1 | 2009 | 1064 | 0.020 |
Why?
| Intubation, Intratracheal | 1 | 1988 | 202 | 0.020 |
Why?
| Hereditary Sensory and Autonomic Neuropathies | 1 | 1985 | 3 | 0.020 |
Why?
| Iran | 2 | 2000 | 53 | 0.020 |
Why?
| Pyoderma Gangrenosum | 1 | 2004 | 4 | 0.020 |
Why?
| Radiography, Thoracic | 1 | 1986 | 182 | 0.020 |
Why?
| Aging | 1 | 2015 | 1713 | 0.020 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 2 | 2000 | 291 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2004 | 109 | 0.020 |
Why?
| Cytokines | 2 | 1990 | 1981 | 0.020 |
Why?
| Injections, Intramuscular | 1 | 2004 | 127 | 0.020 |
Why?
| Adipose Tissue | 1 | 1988 | 662 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 1984 | 441 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1141 | 0.020 |
Why?
| Bone Marrow Examination | 1 | 1982 | 7 | 0.020 |
Why?
| Cell Aggregation | 3 | 1988 | 26 | 0.020 |
Why?
| Hypergammaglobulinemia | 1 | 1982 | 9 | 0.020 |
Why?
| Debridement | 1 | 2003 | 89 | 0.020 |
Why?
| Splenomegaly | 1 | 1982 | 16 | 0.020 |
Why?
| Finger Joint | 1 | 1982 | 8 | 0.020 |
Why?
| Measles Vaccine | 1 | 1982 | 19 | 0.020 |
Why?
| Animals | 6 | 2004 | 35394 | 0.020 |
Why?
| Hepatitis B Surface Antigens | 1 | 2002 | 14 | 0.020 |
Why?
| Hepatitis B Antibodies | 1 | 2002 | 10 | 0.020 |
Why?
| Measles | 1 | 1982 | 27 | 0.020 |
Why?
| T-Lymphocytes | 1 | 1991 | 1846 | 0.020 |
Why?
| Myositis | 1 | 1982 | 42 | 0.020 |
Why?
| Arthritis, Infectious | 1 | 1982 | 42 | 0.020 |
Why?
| Serologic Tests | 1 | 2002 | 61 | 0.020 |
Why?
| Elbow Joint | 1 | 1982 | 67 | 0.010 |
Why?
| Chemotherapy, Adjuvant | 1 | 2003 | 325 | 0.010 |
Why?
| Phospholipids | 1 | 1983 | 205 | 0.010 |
Why?
| Wrist | 1 | 2002 | 40 | 0.010 |
Why?
| Opsonin Proteins | 1 | 2001 | 26 | 0.010 |
Why?
| Chondrocalcinosis | 1 | 2001 | 2 | 0.010 |
Why?
| Disease Susceptibility | 1 | 1983 | 357 | 0.010 |
Why?
| Clinical Chemistry Tests | 1 | 2001 | 11 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 2052 | 0.010 |
Why?
| Hematologic Tests | 1 | 2001 | 26 | 0.010 |
Why?
| Receptors, Complement | 1 | 2001 | 128 | 0.010 |
Why?
| Anemia, Hypochromic | 1 | 2000 | 6 | 0.010 |
Why?
| Occupations | 1 | 2001 | 43 | 0.010 |
Why?
| Therapeutic Equivalency | 1 | 2000 | 22 | 0.010 |
Why?
| Triglycerides | 1 | 1983 | 554 | 0.010 |
Why?
| Antibodies, Bacterial | 1 | 2001 | 137 | 0.010 |
Why?
| Thyroid Diseases | 1 | 2001 | 38 | 0.010 |
Why?
| Etanercept | 1 | 2000 | 54 | 0.010 |
Why?
| Salmonella typhi | 1 | 1980 | 13 | 0.010 |
Why?
| Reoperation | 1 | 2003 | 538 | 0.010 |
Why?
| Pneumococcal Infections | 1 | 2001 | 96 | 0.010 |
Why?
| Brain Edema | 1 | 2001 | 68 | 0.010 |
Why?
| Delayed-Action Preparations | 1 | 2001 | 173 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 38 | 0.010 |
Why?
| Shigella flexneri | 1 | 1980 | 12 | 0.010 |
Why?
| Laser Coagulation | 1 | 2000 | 46 | 0.010 |
Why?
| Antitubercular Agents | 1 | 2002 | 166 | 0.010 |
Why?
| Thymus Gland | 1 | 2001 | 289 | 0.010 |
Why?
| Histocompatibility Antigens Class II | 1 | 1982 | 382 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2001 | 463 | 0.010 |
Why?
| Placebos | 1 | 2000 | 216 | 0.010 |
Why?
| Furosemide | 1 | 2000 | 30 | 0.010 |
Why?
| Microsatellite Repeats | 1 | 2000 | 170 | 0.010 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2000 | 112 | 0.010 |
Why?
| Amino Acid Sequence | 2 | 2000 | 2229 | 0.010 |
Why?
| Serum Sickness | 1 | 1999 | 6 | 0.010 |
Why?
| Folic Acid | 2 | 1990 | 153 | 0.010 |
Why?
| Diuretics | 1 | 2000 | 84 | 0.010 |
Why?
| Antibodies, Anticardiolipin | 1 | 1998 | 7 | 0.010 |
Why?
| Hepatitis, Autoimmune | 1 | 1999 | 31 | 0.010 |
Why?
| Neoplasms | 1 | 1993 | 2037 | 0.010 |
Why?
| Calcitonin | 1 | 1999 | 31 | 0.010 |
Why?
| Endoscopy, Digestive System | 1 | 2000 | 117 | 0.010 |
Why?
| Genetic Linkage | 1 | 2000 | 364 | 0.010 |
Why?
| Iatrogenic Disease | 1 | 1999 | 50 | 0.010 |
Why?
| Freezing | 2 | 1969 | 123 | 0.010 |
Why?
| Serum Albumin | 1 | 2000 | 161 | 0.010 |
Why?
| Appendectomy | 1 | 1998 | 64 | 0.010 |
Why?
| Arthralgia | 1 | 1998 | 49 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 2000 | 599 | 0.010 |
Why?
| Estrogen Replacement Therapy | 1 | 1999 | 131 | 0.010 |
Why?
| Gene Expression | 1 | 2004 | 1588 | 0.010 |
Why?
| Laparotomy | 1 | 1998 | 108 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2000 | 344 | 0.010 |
Why?
| Kinetics | 1 | 2001 | 1800 | 0.010 |
Why?
| Functional Laterality | 1 | 1998 | 258 | 0.010 |
Why?
| Gold Radioisotopes | 1 | 1977 | 1 | 0.010 |
Why?
| Lymphocytes | 2 | 1969 | 392 | 0.010 |
Why?
| Poly I | 1 | 1976 | 3 | 0.010 |
Why?
| Poly A-U | 1 | 1976 | 4 | 0.010 |
Why?
| Sacroiliac Joint | 1 | 1997 | 31 | 0.010 |
Why?
| Poly C | 1 | 1976 | 5 | 0.010 |
Why?
| Yttrium Radioisotopes | 1 | 1977 | 22 | 0.010 |
Why?
| Skin Diseases, Vascular | 1 | 1996 | 9 | 0.010 |
Why?
| Occupational Diseases | 1 | 1998 | 146 | 0.010 |
Why?
| Peroxidase | 1 | 1996 | 207 | 0.010 |
Why?
| Escherichia coli | 1 | 1980 | 812 | 0.010 |
Why?
| Infant Welfare | 1 | 1995 | 8 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1978 | 1268 | 0.010 |
Why?
| Base Sequence | 1 | 2000 | 2321 | 0.010 |
Why?
| RNA, Messenger | 1 | 2004 | 2857 | 0.010 |
Why?
| Case-Control Studies | 1 | 2003 | 3369 | 0.010 |
Why?
| Patient Education as Topic | 1 | 2001 | 739 | 0.010 |
Why?
| Bone Density | 1 | 1999 | 401 | 0.010 |
Why?
| Vaccines, Inactivated | 1 | 1995 | 60 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 1997 | 0.010 |
Why?
| Spirometry | 1 | 1995 | 276 | 0.010 |
Why?
| Glucose | 2 | 1969 | 887 | 0.010 |
Why?
| Europe | 1 | 1994 | 351 | 0.010 |
Why?
| Body Mass Index | 1 | 2000 | 2098 | 0.010 |
Why?
| Osteomyelitis | 1 | 1993 | 105 | 0.010 |
Why?
| Necrosis | 1 | 1972 | 232 | 0.010 |
Why?
| Endopeptidases | 1 | 1990 | 77 | 0.010 |
Why?
| Prostheses and Implants | 1 | 1972 | 157 | 0.010 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1991 | 139 | 0.010 |
Why?
| Spondylitis | 1 | 1969 | 2 | 0.010 |
Why?
| Dinitrophenols | 1 | 1969 | 8 | 0.010 |
Why?
| Cell Line | 1 | 1976 | 3016 | 0.010 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2003 | 2041 | 0.010 |
Why?
| Lymphoma | 1 | 1990 | 180 | 0.010 |
Why?
| Quality of Life | 1 | 2000 | 2136 | 0.010 |
Why?
| Depression, Chemical | 1 | 1989 | 31 | 0.010 |
Why?
| Lactates | 1 | 1969 | 89 | 0.010 |
Why?
| Hydrogen | 1 | 1969 | 69 | 0.010 |
Why?
| Interleukin-2 | 1 | 1990 | 415 | 0.010 |
Why?
| Drug Interactions | 1 | 1990 | 423 | 0.010 |
Why?
| Health Promotion | 1 | 1995 | 664 | 0.010 |
Why?
| Immunity, Cellular | 1 | 1990 | 307 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1990 | 1041 | 0.010 |
Why?
| Multiple Trauma | 1 | 1989 | 100 | 0.010 |
Why?
| Arthrography | 1 | 1988 | 22 | 0.010 |
Why?
| Mice | 3 | 1990 | 15641 | 0.010 |
Why?
| Lung Diseases | 1 | 1995 | 750 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 1987 | 165 | 0.010 |
Why?
| Iodine Radioisotopes | 1 | 1987 | 131 | 0.010 |
Why?
| Tissue Distribution | 1 | 1987 | 383 | 0.010 |
Why?
| Autoimmunity | 1 | 1993 | 776 | 0.010 |
Why?
| Cell Adhesion | 1 | 1988 | 474 | 0.010 |
Why?
| Suicide, Attempted | 1 | 1989 | 258 | 0.000 |
Why?
| Hemodynamics | 1 | 1991 | 1099 | 0.000 |
Why?
| Hypertension | 1 | 1995 | 1185 | 0.000 |
Why?
| Poland | 1 | 1985 | 28 | 0.000 |
Why?
| Bacterial Infections | 1 | 1987 | 217 | 0.000 |
Why?
| Virus Diseases | 1 | 1987 | 181 | 0.000 |
Why?
| Leukocyte Count | 1 | 1985 | 325 | 0.000 |
Why?
| Vitreous Body | 1 | 1985 | 102 | 0.000 |
Why?
| Amyloid | 1 | 1985 | 91 | 0.000 |
Why?
| Statistics as Topic | 1 | 1985 | 365 | 0.000 |
Why?
| Erythrocytes | 1 | 1969 | 609 | 0.000 |
Why?
| Preoperative Care | 1 | 1986 | 339 | 0.000 |
Why?
| Tuberculosis | 1 | 1986 | 228 | 0.000 |
Why?
| HLA-DR1 Antigen | 1 | 1982 | 1 | 0.000 |
Why?
| Injections, Intra-Articular | 1 | 1982 | 40 | 0.000 |
Why?
| Rats, Inbred Strains | 1 | 1982 | 536 | 0.000 |
Why?
| Neutrophils | 1 | 1985 | 1324 | 0.000 |
Why?
| Lung Neoplasms | 1 | 1986 | 2184 | 0.000 |
Why?
| Methods | 1 | 1972 | 81 | 0.000 |
Why?
| Knee | 1 | 1972 | 49 | 0.000 |
Why?
|
|
Yaron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|